Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Papi (Ferrara, Italy), I. Pavord (Oxford, United Kingdom), J. Fitzgerald (Vancouver, Canada), J. Corren (Los Angeles, United States of America), P. Bardin (Melbourne and Clayton, Australia), H. Park (Suwon, Republic of Korea), M. Rice (Cambridge, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Ruddy (Tarrytown, United States of America), N. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America). Dupilumab Efficacy in Asthma Patients With FEV1 60–80% Predicted on Medium-Dose ICS: LIBERTY ASTHMA QUEST Study. 538

Member's Comments

No comment yet.

Related content which might interest you: Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Prevalence and Risk Factors of Asthma and Allergy-Related Diseases among Adolescents (PERFORMANCE) study: rationale and methods Source: ERJ Open Res, 4 (2) 00034-2018; 10.1183/23120541.00034-2018 Year: 2018 Long-term (5 year) safety of bronchial thermoplasty in patients with moderate to severe asthma: Asthma Intervention Research (AIR) Trial Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results. Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news Year: 2019 Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Perception and Usage Among Indian Physicians of Long Acting Dual Bronchodilators in COPD: PATTERN Study Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 FENO Guided Therapy in Asthma: A Non-inferiority Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Efficacy of dupilumab in patients with oral corticosteroid (OCS)-dependent, severe asthma with and without an allergic phenotype: phase 3 LIBERTY ASTHMA VENTURE Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Late Breaking Abstract - Sensibility and specificity of the “SLEEP CLINICAL RECORD” Protocol  in Brazilian children. Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children Year: 2018 As-needed formoterol (F) in asthma: An analysis of the East-Asian subgroup of the RELIEF study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Awareness campaigns on the WORLD COPD Day Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Evolution in the prescription of the therapy combined with ICS-LABA in COPD: TRACE STUDY Source: International Congress 2017 – Markers of COPD progression Year: 2017 Evaluation Of 24-Hour Day Respiratory Symptoms And GOLD Classification System In COPD Patients From Seven Latin America Countries: The LASSYC Study Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018